INTRODUCTION

For the detection and diagnosis of whooping cough in your laboratory

The resurgence of whooping cough worldwide will result in the diagnosis of more than 50 million adults, teenagers, and young children annually. With increased pressure to reduce hospital admissions, reliable detection with accelerated response times is important in managing patient treatment.

Molecular testing with our Simplexa Bordetella real-time PCR assay can aid in the quick differential detection and diagnosis of B. pertussis and B. parapertussis. Our expertise in respiratory testing will help you be the solution for the diagnosis of whooping cough.

TEST PRINCIPLE AND PROCEDURE

Focus Diagnostics and 3M Health Care introduce the innovative 3M™ Integrated Cycler to run real-time PCR for:

• Quantitative detection
• Qualitative detection
• Mulit-analyte detection

The 3M Integrated Cycler is the stepping stone to putting new technology in your lab:

Small Footprint

• Length: 31cm (12”)
• Width: 21cm (8”)
• Height: 31cm (12”)

Lightweight

• Less than 8 kg (17 lb)

Regular Power Requirements

• 110/220 volt compatible

Fast Ramp Rates

• Heating > 5°C/sec
• Cooling > 4°C/sec

Universal Disc

• Single-use disc with 96-well capacity

Direct Amplification Disc

• Multi-use disc with 8-well capacity

Simple Barcode Scanning

• For easy sample load

Scalable

• From the amplification of preprocessed samples to full integration

Further information on Simplexa™ and 3M™ Integrated Cycler

EVALUATION

The performance of the Simplexa Bordetella assay was high for both Bordetella pertussis and Bordetella parapertussis when compared to the predicate device.*

* Predicate device was the Focus Diagnostics Bordetella kit (MOL0200)

COMMERCIAL PRODUCT